These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16232228)

  • 1. Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine.
    Zuercher AW; Imboden MA; Jampen S; Bosse D; Ulrich M; Chtioui H; Lauterburg BH; Lang AB
    Clin Exp Immunol; 2005 Nov; 142(2):381-7. PubMed ID: 16232228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine.
    Zuercher AW; Imboden MA; Jampen S; Bosse D; Ulrich M; Chtioui H; Lauterburg BH; Lang AB
    Clin Exp Immunol; 2006 Jan; 143(1):132-8. PubMed ID: 16367944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune responses to a killed Salmonella enteritidis vaccine: lymphocyte proliferation, T-cell changes and interleukin-6 (IL-6), IL-1, IL-2, and IFN-gamma production.
    Okamura M; Lillehoj HS; Raybourne RB; Babu US; Heckert RA
    Comp Immunol Microbiol Infect Dis; 2004 Jul; 27(4):255-72. PubMed ID: 15178000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gammadelta T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-alpha and IFN-gamma-producers in response to Pseudomonas aeruginosa.
    Raga S; Julià MR; Crespí C; Figuerola J; Martínez N; Milà J; Matamoros N
    Respir Res; 2003; 4(1):9. PubMed ID: 14525626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Sadoff JC; Ohman D; Fürer E
    J Lab Clin Med; 1988 Jun; 111(6):701-7. PubMed ID: 3131471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G; Dorner F
    Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator "Dentavax".
    Petrunov B; Marinova S; Markova R; Nenkov P; Nikolaeva S; Nikolova M; Taskov H; Cvetanov J
    Int Immunopharmacol; 2006 Jul; 6(7):1181-93. PubMed ID: 16714223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
    J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
    Cryz SJ; Fürer E; Cross AS; Wegmann A; Germanier R; Sadoff JC
    J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.
    Fernandez V; Andersson J; Andersson U; Troye-Blomberg M
    Eur J Immunol; 1994 Aug; 24(8):1808-15. PubMed ID: 8056039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Sadoff JC; Fürer E
    Microb Pathog; 1989 Jan; 6(1):75-80. PubMed ID: 2733597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.